- An open-source, apartment-kitchen-scale synthesis route for Tamiflu (oseltamivir) was circulated, including extraction of shikimic acid from star anise or sweetgum to bypass the $115/g commercial price, with a university lab set to test the Corey or Trost synthetic routes.  
- A debate on realistic molecular-cell simulation contrasted Harvard’s smooth “Inner Life of the Cell” with the need for “jittery” Brownian motion, citing Alan Kay’s argument that molecular recognition only makes sense when thermal chaos is visible.  
- DIY-bio risk perception was discussed via a Genetic Engineering News article on societal paranoia toward citizen bioengineers, alongside the launch of a curated news feed (bit.ly/diybionews) for ongoing coverage.  
- Copenhagen Suborbitals’ amateur-rocket program drew concern that a high-profile failure could trigger tighter regulation, countered by arguments that sub-orbital debris re-enters quickly and voluntary risk should be celebrated.  
- Kriorus announced that its first full-body cryonics dewar, “Anabiosis-1,” entered final vacuum tests with patient transfers scheduled for 10–14 September 2010.  
- RepRap-style 3-D printing is being adapted for tissue engineering: a UPenn post-doc released GitHub repos for MakerBot, Skeinforge, and SkeinFox, while browser-based CAD workflows using three.js and cloudscad were demoed for G-code/STL viewing.  
- A $10 trillion patent-lawsuit document (intellectual_property6-11-10.pdf) was mocked for claiming U.S. IP exports exceed 40 % of GDP and demanding border crackdowns to protect $5.5 T in intangible assets.  
- Cryonics strategy discussion centered on Alcor’s model of funding perpetual liquid-nitrogen storage through managed pension funds to hedge against organizational bankruptcy, alongside philosophical disagreement over whether near-term suspension is “equivalent to dying” versus a rational choice of one’s moment of death.